Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

Loading...

Exclusive Interview
Interview with Mark Crane
VP business development and marketing, Ricerca

By Nick Taylor, 17-Feb-2010, duration 03:46


Email this page
Contact the editor
RSS feeds

The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president.

Speaking to Outsourcing-Pharma at Informex 2010, Mark Crane, vice president, business development and marketing at Ricerca, explained that services proivided by the MDS' sites take clients up to the developmental stage that Ricerca traditionally began working with companies.

Acquiring the MDS' sites increases Ricerca's headcount from 270 to over 800 and expands the company into new geographies. Despite this, Crane believes that integration will be relatively straightforward because of the lack of overlap between Ricerca's existing capacity and the acquired sites.

Related topics: Globalisation, Consolidation, Preclinical Research, Phase I-II, Phase III-IV, Preclinical

KCAS talks biomarker strategy development

Proveen Dass

Associate Director of ligand binding assay services, KCAS

Almac Diagnostics discusses new biomarker service

Michael Sloan

VP of Business Development, Almac Diagnostics

ERT develops IVR suicidality monitoring for trials

Mike Federico

VP of ePRO solutions, eResearchTechnology

Biomarkers “indispensible” in cancer drug development, says Quintiles

Christopher Ung

VP of strategic business and operations, Quintiles

Data, patients and payers key to “New Health” success, says Quintiles

Jay Norman

President of the consulting group, Quintiles

Safety and value driving Phase IV growth at CROs; EVP

Jeff Trotter

executive vice president Phase IV development, PharmaNet

Potential for trials in Russia "enormous", says ClinStar

Roger Price

Director of business development, Europe, ClinStar

Liquent and Take Solutions team on regulatory submissions

Jeff Huntsman

VP sales and marketing, Liquent

INC forms ePRO partnership with invivodata

Alistair Macdonald

Executive Vice President, Strategic Development, INC Research

Centralising ECG trial data can cut costs 40%, says ERT

John Blakeley

Executive VP sales and marketing, E Research Technology

Quintiles opens Nairobi office

Gillian Corken

CEO, Quintiles Africa

Electronic submission offers benefits for pharma, says ISI

Kate Wilber

Director of European Regulatory Services, Image Solutions

SAFC preparing for inevitable shift to cell culture vaccines

David Backer

Director of Business Development and Marketing, SAFC Pharma

Informex – companies hope for a brighter 2010

There are signs that 2010 will be a...

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

Mark Crane

VP business development and marketing, Ricerca

Trial sponsors and CROs must do more to recruit older people, says EU group

Professor Peter Crome

European Union PREDICT group, Keele University, UK

MENA emerging as trial destination says ClinTec CEO

Dr Rabinder Buttar

CEO, ClinTec International

Adaptive methods can improve personalised medicine trials; CEO

Michael Rosenberg

CEO, Health Decisions

AAPS - trends in turbulent times

AAPS 2009 has drawn to a close but...

AAPS - round up of day one

Following the first full day of AAPS 2009...

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

Gerben Moolhuizen, OctoPlus and Hans Baumeister, Glycotope

James Easson, Merk KGaA, Shirley Dann, SCM Pharma

CPhI 2009 - Road to recovery?

As CPhI 2009 draws to a close we...

Gene therapy to drive viral and biologics market, says SAFC

David Backer

Business development and marketing director, SAFC Pharma

CPhI 2009 show preview

We look ahead to CPhI 2009 which takes...

Transcrip offers experts to augment in-house drug development

Paul Branthwaite

Senior partner, TranScrip Partners

Intelligent packaging can cut cost of trials; Stora Enso

Sari Hakli

Sales Manager, Pharmaceutical Solutions , Stora Enso

Seasonal Video Greetings From Decision News Media

Welcome to this seasonal holiday video from Decision...

Meet Our New Owners

Don’t miss this video interview with Robert...

PTI unveils Toyo's "stick pack" system at Interphex

Jeffrey Crangle

General manager, PTI Packaging Systems

Drugmakers still confused by CFR-21 parts 210 and 211, says West

Jennifer Riter

Director of analytical and technical services, West Pharmaceutical Services

Flexibility is key for processing sector says Millipore

Paul Chapman

VP, Downstream Processing, Millipore

Pharma mega mergers a boon for Patheon's restructuring service, says CEO

Wesley Wheeler

Chief Executive Officer & President, Patheon

Amcor takes a flexible approach to packaging

Javier Rojo, executive VP of sales and marketing

Pedro Bezares, product development manager, Amcor Flexibles

NAF & VSM look to clean up in pre-washed vial market

Martijn Eijkenboom

President, NAF & VSM

Video season's greetings from Decision News Media

The Decision News Media team would like to...

EFCG talks excipient certification

Tim Bölke

Head of excipient taskforce, European Fine Chemicals Group

SAFC showcases HPAPI handling capabilities

Mike Harris

Managing Director UK and Ireland, Sigma Aldrich, Vice President ,...